European Distribution Partnership between NeuroproteXeon and Linde |
May 09, 2018 | May 2018 Bond Updates |
ABINGDON, England, May 9, 2018 /PRNewswire/ -- NeuroproteXeon announced today that they have completed a distribution agreement with Linde AG (Lin.de) for XENEX™ (xenon by inhalation) for Post Cardiac Arrest Syndrome ("PCAS") for the European Union plus United Kingdom, Switzerland, Norway... |
View more at: https://www.prnewswire.com/news-releases/european-distribution-partnership-between-neuroprotexeon-and-linde-300644969.html |
Related News |